Skip to content
Governance Register

← US public companies

Kyverna Therapeutics, Inc.

SEC CIK 1994702 · KYTX · last insider filing 2026-05-29

Directors (from insider filings)

NameCapacity as filedFilings
Seidenberg Beth C Director filed 2024 - 2026
Clark IAN T Director filed 2024 - 2026
Cohen Fred E Director filed 2024 - 2026
Shaw Christi Director · Executive Chairperson filed 2024 - 2026
Aktar Mert Director filed 2024 - 2026
Biddle Warner Weston Director · Chief Executive Officer filed 2024 - 2026
Miller Andrew Craig Director filed 2026 - 2026
Emany Sravan Kumar Director filed 2026 - 2026
Spiegelman Daniel K Director filed 2024 - 2025
Liapis Stephen Constantine Director filed 2024 - 2024
Maag Peter Director · Chief Executive Officer filed 2024 - 2024
Kotzin Brian L. Director filed 2024 - 2024

Officers (from insider filings)

NameTitle as filedFilings
Martini Gregory S. Chief Financial Officer filed 2026 - 2026
Dac Nadia Chief Commercial Officer filed 2026 - 2026
Grasso Marc Chief Financial Officer filed 2025 - 2026
Gehchan Naji See Remarks filed 2025 - 2026
Pujols Mayobanex Chief Technology Officer filed 2026 - 2026
Walker Karen Marie Chief Technology Officer filed 2024 - 2025
Jones Ryan Alexander Chief Financial Officer filed 2024 - 2025
Chung James Bum Chief Medical Officer filed 2024 - 2024
Borie Dominique Christian See Remarks filed 2024 - 2024

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.